| ISIN | CH0435830630 |
|---|---|
| Valor Number | 43583063 |
| Bloomberg Global ID | ZKBASCI SW |
| Fund Name | ZugerKB Fonds - Aktien ESG Schweiz (CHF) I |
| Fund Provider |
Zuger Kantonalbank AG, Zug
Baarerstrasse 37 6301 Zug Phone: +41 41 709 11 11 |
| Fund Provider | Zuger Kantonalbank AG, Zug |
| Representative in Switzerland | |
| Distributor(s) | Zuger Kantonalbank, Zug |
| Asset Class | Equities |
| EFC Category | Equity Switzerland |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | Das Anlageziel des Teilvermögens ZugerKB Fonds - Aktien Schweiz (CHF) besteht in einem langfristig möglichst hohen Anlageertrag in der Rechnungseinheit CHF. |
| Peculiarities |
| Current Price * | 167.46 CHF | 06.01.2026 |
|---|---|---|
| Previous Price * | 166.59 CHF | 05.01.2026 |
| 52 Week High * | 167.46 CHF | 06.01.2026 |
| 52 Week Low * | 138.94 CHF | 09.04.2025 |
| NAV * | 167.46 CHF | 06.01.2026 |
| Issue Price * | 167.46 CHF | 06.01.2026 |
| Redemption Price * | 167.46 CHF | 06.01.2026 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 256,324,780 | |
| Unit/Share Assets *** | 69,203,978 | |
| Trading Information SIX | ||
| YTD Performance | +0.80% |
31.12.2025 - 06.01.2026
31.12.2025 06.01.2026 |
|---|---|---|
| 1 month | +2.50% |
08.12.2025 - 06.01.2026
08.12.2025 06.01.2026 |
| 3 months | +5.20% |
06.10.2025 - 06.01.2026
06.10.2025 06.01.2026 |
| 6 months | +7.53% |
07.07.2025 - 06.01.2026
07.07.2025 06.01.2026 |
| 1 year | +10.54% |
06.01.2025 - 06.01.2026
06.01.2025 06.01.2026 |
| 2 years | +21.17% |
08.01.2024 - 06.01.2026
08.01.2024 06.01.2026 |
| 3 years | +30.11% |
06.01.2023 - 06.01.2026
06.01.2023 06.01.2026 |
| 5 years | +35.76% |
06.01.2021 - 06.01.2026
06.01.2021 06.01.2026 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| UBS Group AG Registered Shares | 9.08% | |
|---|---|---|
| Roche Holding AG | 8.56% | |
| Nestle SA | 7.31% | |
| Novartis AG Registered Shares | 6.80% | |
| Lonza Group Ltd | 6.68% | |
| Zurich Insurance Group AG | 5.47% | |
| ABB Ltd | 4.90% | |
| Swiss Life Holding AG | 4.55% | |
| Compagnie Financiere Richemont SA Class A | 4.20% | |
| Swiss Re AG | 3.88% | |
| Last data update | 30.09.2025 | |
| TER | 0.65% |
|---|---|
| TER date | 31.05.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.60% |
| Ongoing Charges *** | 0.67% |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |